布林西多福维尔在活体中抑制了多病毒感染
Arrienne B Butic1, Zoe E Katz1, Ge Jin1
1Department of Microbiology and Immunology, Penn State College of Medicine, Hershey, Pennsylvania, USA.
mBio
|July 2, 2024
概括
布林西多福维尔有效地对抗小鼠中的多重病毒感染,减少病毒载量和病理. 这种抗病毒药物对治疗人类多瘤病毒感染有前途,特别是在免疫功能低下的人群中.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多种病毒是常见的DNA病毒,在免疫功能低下的人群中引起重大疾病.
- 目前还没有经批准的抗病毒药物用于治疗多瘤病毒感染,因此需要替代治疗方法.
- 目前的管理包括减少免疫抑制,降低移植排斥和免疫反应的风险.
研究的目的:
- 为了研究布林西多福维尔 (BCV) 对多病毒感染的疗效.
- 为了评估BCV的抗病毒活性,在体外和体内使用小鼠多瘤病毒 (MuPyV).
- 评估BCV作为治疗人类多瘤病毒感染的治疗剂的潜力.
主要方法:
- 在实验室研究中使用初级小鼠脏和大脑皮质细胞.
- 在体内研究涉及小鼠的BCV预防和治疗.
- 评估病毒DNA,RNA,蛋白质水平和传染性病毒的产生.
主要成果:
- 在细胞培养中,BCV抑制了MuPyV的产生,在细胞进入后起作用.
- 在小鼠中,BCV耐受性良好,减少了和大脑中的病毒DNA和传染性病毒.
- 在慢性感染的小鼠中,治疗性BCV给药降低了病毒病和脏感染.
结论:
- 布林西多福维尔在体内显示出针对多病毒感染的显著抗病毒活性.
- 在小鼠模型中,BCV治疗减少了病毒载量和病理.
- 这些发现支持进一步研究BCV用于治疗人类多瘤病毒感染.
相关概念视频
Retroviruses
12.2K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.2K
Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Retrovirus Life Cycles
45.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.8K
Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K


